A Trace ‘Tides Primer: Understanding the dinucleotide coenzyme and its related compounds

By: Laura Mildon

NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme found in living cells. It participates in many enzyme-driven reactions and is widely studied in cellular metabolism. Although often discussed alongside peptides, NAD+ is chemically different: it is a dinucleotide, not a chain of amino acids.

What is a coenzyme

An enzyme helps a chemical reaction occur. A coenzyme is a small organic molecule that assists an enzyme in its work. NAD+ can accept electrons during certain reactions, becoming NADH. In other reactions, enzymes use and break down NAD+ as a chemical substrate.

These biochemical roles do not establish an energy, longevity, or other health benefit for a commercially supplied NAD+ product.

Review of NAD metabolism and cellular compartmentalization

Chemical identity

The formula and weight above refer to the database’s free-acid representation. Salts, hydration, and protonation states require separate identification. The plus sign is part of the conventional name for the oxidized form and reflects its nicotinamide ring; it does not indicate product strength.

PubChem chemical identity and molecular structure

What does dinucleotide mean

A nucleotide contains a base, a sugar, and a phosphate group. NAD+ contains two nucleotide units joined through their phosphate groups. One carries adenine; the other carries nicotinamide. Both contain ribose sugars. It has no amino acid sequence or peptide backbone.

NAD+ and NADH

NAD+ and NADH are a paired oxidized and reduced chemical system. NAD+ accepts a hydride—two electrons together with a hydrogen nucleus—at its nicotinamide ring to become NADH. NADH can transfer those electrons in subsequent reactions, regenerating NAD+.

Researchers compare NAD+ and NADH to investigate redox, or electron-transfer, chemistry. Their different chemical states mean they are not interchangeable in every experiment.

History and origins

NAD research grew out of studies of yeast fermentation. In 1906, Arthur Harden and William John Young described a heat-stable, diffusible “coferment” needed for fermentation in yeast juice. Their work helped establish the idea that enzymes could require an additional small chemical component.

This was an early functional discovery, rather than a complete determination of NAD’s modern chemical structure. Subsequent purification and structural work clarified the coenzyme. Its research history later expanded beyond electron transfer to include enzymes that consume NAD+ during protein modification and signaling reactions.

Harden and Young’s original coferment paper from 1906

Selected published research

These studies illustrate distinct questions in NAD+ research: enzyme activity, biosynthetic pathways, and transport between cellular compartments. They do not establish an intended application for a research product.

NAD-dependent enzyme activity in 2000

Imai and colleagues demonstrated that yeast and mouse Sir2 proteins required NAD for histone deacetylation. Histones help package DNA; deacetylation removes particular chemical groups from these proteins. This helped establish a link between NAD chemistry and the regulation of protein function.

The work concerns a defined enzyme mechanism. It does not establish that a NAD+ product extends lifespan or reproduces the experimental findings in another setting.

Read the original study in Nature

An NAD precursor pathway in 2004

Bieganowski and Brenner identified nicotinamide riboside, or NR, as a precursor for NAD+ synthesis in yeast and characterized relevant kinase enzymes from yeast and humans. A kinase transfers a phosphate group to another molecule.

The study helps explain how a chemically distinct precursor can enter an NAD biosynthetic pathway. It does not make NR and NAD+ the same molecule, or establish a benefit for a marketed formulation.

Read the original study in Cell

Mitochondrial transport in 2020

Luongo and colleagues identified SLC25A51 as a mammalian mitochondrial NAD+ transporter. Using cellular and mitochondrial experiments, they investigated how NAD+ reaches mitochondria, specialized compartments involved in metabolism.

This finding emphasizes that location matters: NAD+ measured in one part of a cell does not necessarily describe the amount available in another. Mitochondrial transport is also a different question from how an external commercial product behaves.

Read the original study in Nature

PubChem record for the reduced form NADH

Related names that should not be confused

A precursor is a starting material used to make another molecule. NR and NMN can participate in pathways that generate NAD+, but their chemistry and experimental behavior differ. A finding about a precursor should not automatically be described as a finding about NAD+ itself.

Scientific review of NR and NMN as NAD intermediates

Why capsule labels can create confusion

A package marketed around “NAD+ support” may list NAD+ itself, a precursor, or a blend. The ingredient panel must identify the actual compounds; the front-label phrase alone does not establish their identity.

Retail availability does not establish FDA drug approval, verify product contents, or make a laboratory research material interchangeable with a finished supplement.

What remains unresolved

NAD+ biochemistry is well established, but product claims require separate evidence. Researchers distinguish between changes in NAD concentration, changes in the NAD+/NADH ratio, effects on a specific enzyme, and meaningful outcomes in a whole experimental system.

Cells also maintain NAD in different compartments. An increase in a blood measurement or one cellular compartment does not establish an increase everywhere, nor does it automatically demonstrate a health benefit. The molecule studied, sample measured, and experimental model must remain explicit.

Review of NAD metabolism and current research challenges

Regulatory context

FDA does not generally approve dietary supplements before marketing. Ingredients and finished products must still meet applicable requirements. A retail supplement label does not authorize a research material for another intended use.

FDA explanation of dietary supplement regulation

NAD+ research materials are not FDA-approved medicines. FDA has cautioned that food-grade NAD+ is unsuitable for sterile drug compounding. This concerns material quality in a specific manufacturing context, not a blanket prohibition on NAD+ research.

FDA notice on NAD+ ingredient quality and compounding

Research and regulatory sources checked October 13, 2026.

DISCLAIMER: These statements are for research purposes only and have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Why choose Trace 'Tides? 

Because trust starts with real people, clear answers, and quality you can verify. We have a certified peptide specialist on staff, a phone number that connects you with a real human, and a physical location you can visit by appointment. Call or text us—we’re delighted to answer your questions and address your concerns. We also make checkout straightforward by accepting credit cards, without asking you to use cryptocurrency or connect your bank account to an unfamiliar payment app. And every peptide we sell is tested for purity and endotoxins by licensed U.S. laboratories, so you can choose your research peptides with confidence.